Fulvestrant
NDC 68001-484, Fulvestrant, injection, solution, from BluePoint Laboratories.
- Product NDC
- 68001-484
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210044
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FULVESTRANT250 mg/5mL
Pharmacologic classes
Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-484-85 | 68001048485 | 2 SYRINGE, GLASS in 1 CARTON (68001-484-85) / 5 mL in 1 SYRINGE, GLASS (68001-484-86) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bc7b4eac-3b63-53d2-e053-2995a90ad5e7Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=68001-484
Use it
Look up 68001-484 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-484. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.